CD4-positive T-helper cell responses to the PASD1 protein in patients with diffuse large B-cell lymphoma.

BACKGROUND: Vaccine development targeting the novel immunogenic Per ARNT Sim Domain containing 1 (PASD1) cancer testis antigen represents an attractive therapeutic approach for the significant number of patients with diffuse large B-cell lymphoma who are refractory to conventional treatment. Since...

詳細記述

書誌詳細
主要な著者: Ait-Tahar, K, Liggins, A, Collins, G, Campbell, A, Barnardo, M, Cabes, M, Lawrie, C, Moir, D, Hatton, C, Banham, A, Pulford, K
フォーマット: Journal article
言語:English
出版事項: 2011